Description

Clopidogrel-TEVA Coated Tablets 75 mg. №30

Ingredients

Active ingredient: Clopidogrel bisulfate. Inactive ingredients: mannitol, microcrystalline cellulose, croscarmellose sodium, hydroxypropyl cellulose, hydroxypropyl cellulose, and more.

Dosage

Recommended dosage: The usual dose is one tablet daily, with or without food, or as directed by a healthcare professional.

Indications

Indicated for: Prevention of atherothrombotic events in patients suffering from acute coronary syndrome, recent myocardial infarction, stroke, or established peripheral arterial disease.

Contraindications

Do not use if: Hypersensitive to clopidogrel or any component of the formulation, active pathological bleeding, or hepatic impairment.

Directions

Administration: Swallow the tablet whole with water. Do not crush or chew. Consult a doctor before starting or stopping this medication.

Scientific Evidence

Clopidogrel-TEVA has been extensively studied in various clinical trials, demonstrating its efficacy in reducing cardiovascular events. Research published in the New England Journal of Medicine showed a significant reduction in the risk of cardiovascular death, myocardial infarction, or stroke with clopidogrel therapy compared to placebo.

Additional Information

Precautions: Clopidogrel may increase the risk of bleeding, so caution is advised in patients with a history of gastrointestinal bleeding, recent surgery, or trauma. It is important to inform healthcare providers about all medications being taken to prevent potential drug interactions.

Pharmacological Effects: Clopidogrel is a platelet aggregation inhibitor that works by irreversibly binding to the P2Y12 ADP receptor on platelets, preventing platelet activation and aggregation. This antiplatelet effect reduces the risk of thrombotic events in patients with atherosclerosis.